• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定和分析肥厚型心肌病中与缺氧和免疫相关的关键基因。

Identification and analysis of key hypoxia- and immune-related genes in hypertrophic cardiomyopathy.

机构信息

School of Basic Medical Sciences, Shaanxi University of Chinese Medicine, Xianyang, 712046, China.

University of Southern California, Los Angeles, CA, 90089, USA.

出版信息

Biol Res. 2023 Aug 9;56(1):45. doi: 10.1186/s40659-023-00451-4.

DOI:10.1186/s40659-023-00451-4
PMID:37559135
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10410988/
Abstract

BACKGROUND

Hypertrophic cardiomyopathy (HCM), an autosomal dominant genetic disease, is the main cause of sudden death in adolescents and athletes globally. Hypoxia and immune factors have been revealed to be related to the pathology of HCM. There is growing evidence of a role for hypoxia and inflammation as triggers and enhancers in the pathology in HCM. However, the role of hypoxia- and immune-related genes in HCM have not been reported.

METHODS

Firstly, we obtained four HCM-related datasets from the Gene Expression Omnibus (GEO) database for differential expression analysis. Immune cells significantly expressed in normal samples and HCM were then screened by a microenvironmental cell population counter (MCP-counter) algorithm. Next, hypoxia- and immune-related genes were screened by the LASSO + support vector machine recursive feature elimination (SVM-RFE) and weighted gene co-expression network analysis (WGCNA). Single-gene enrichment analysis and expression validation of key genes were then performed. Finally, we constructed a competing endogenous RNA (ceRNA) network of key genes.

RESULTS

In this study, 35 differentially expressed hypoxia genes were found. By using LASSO + SVM-RFE analysis, 10 more targets with differentially expressed hypoxia genes were identified. The MCP-count algorithm yielded five differentially expressed immune cells, and after assessing them for WGCNA characteristics, 612 immune genes were discovered. When hypoxia and immune genes were combined for cross-tabulation analysis, three hypoxia- and immune-related genes (ATP2A2, DDAH1, and OMA1) were identified.

CONCLUSION

Based on hypoxia characteristic genes, three key genes were identified. These were also significantly related to immune activation, which proves a theoretical basis and reference value for studying the relationship between HCM and hypoxia and immunity.

摘要

背景

肥厚型心肌病(HCM)是一种常染色体显性遗传病,是全球青少年和运动员猝死的主要原因。缺氧和免疫因素已被揭示与 HCM 的病理学有关。越来越多的证据表明,缺氧和炎症在 HCM 的病理学中作为触发因素和增强因素起作用。然而,缺氧和免疫相关基因在 HCM 中的作用尚未报道。

方法

首先,我们从基因表达综合数据库(GEO)中获得了四个与 HCM 相关的数据集,用于差异表达分析。然后,通过微环境细胞群体计数器(MCP-counter)算法筛选在正常样本和 HCM 中显著表达的免疫细胞。接下来,通过 LASSO+支持向量机递归特征消除(SVM-RFE)和加权基因共表达网络分析(WGCNA)筛选缺氧和免疫相关基因。然后进行单基因富集分析和关键基因的表达验证。最后,构建关键基因的竞争性内源性 RNA(ceRNA)网络。

结果

本研究发现了 35 个差异表达的缺氧基因。通过 LASSO+SVM-RFE 分析,进一步确定了 10 个具有差异表达缺氧基因的靶点。MCP-count 算法得到了 5 种差异表达的免疫细胞,经过 WGCNA 特征评估,发现了 612 个免疫基因。当将缺氧和免疫基因进行交叉制表分析时,鉴定出了三个与缺氧和免疫相关的基因(ATP2A2、DDAH1 和 OMA1)。

结论

基于缺氧特征基因,鉴定出了三个关键基因。这些基因也与免疫激活显著相关,为研究 HCM 与缺氧和免疫之间的关系提供了理论依据和参考价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d5/10410988/1de5ed5232f8/40659_2023_451_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d5/10410988/c6b3dfa0ac7b/40659_2023_451_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d5/10410988/c24f1d224703/40659_2023_451_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d5/10410988/a3a6e393431a/40659_2023_451_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d5/10410988/3ff1ddb2fe56/40659_2023_451_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d5/10410988/633d1039b2d8/40659_2023_451_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d5/10410988/ef432a5d5306/40659_2023_451_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d5/10410988/1de5ed5232f8/40659_2023_451_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d5/10410988/c6b3dfa0ac7b/40659_2023_451_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d5/10410988/c24f1d224703/40659_2023_451_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d5/10410988/a3a6e393431a/40659_2023_451_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d5/10410988/3ff1ddb2fe56/40659_2023_451_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d5/10410988/633d1039b2d8/40659_2023_451_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d5/10410988/ef432a5d5306/40659_2023_451_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d5/10410988/1de5ed5232f8/40659_2023_451_Fig7_HTML.jpg

相似文献

1
Identification and analysis of key hypoxia- and immune-related genes in hypertrophic cardiomyopathy.鉴定和分析肥厚型心肌病中与缺氧和免疫相关的关键基因。
Biol Res. 2023 Aug 9;56(1):45. doi: 10.1186/s40659-023-00451-4.
2
Characterization of the circulating transcriptome expression profile and identification of novel miRNA biomarkers in hypertrophic cardiomyopathy.肥厚型心肌病循环转录组表达谱特征及新型 miRNA 生物标志物的鉴定。
Eur J Med Res. 2023 Jun 30;28(1):205. doi: 10.1186/s40001-023-01159-7.
3
A personalized mRNA signature for predicting hypertrophic cardiomyopathy applying machine learning methods.应用机器学习方法的预测肥厚型心肌病的个性化 mRNA 特征。
Sci Rep. 2024 Jul 24;14(1):17023. doi: 10.1038/s41598-024-67201-8.
4
Identification of the Immune Status of Hypertrophic Cardiomyopathy by Integrated Analysis of Bulk- and Single-Cell RNA Sequencing Data.通过 bulk 和单细胞 RNA 测序数据的综合分析鉴定肥厚型心肌病的免疫状态。
Comput Math Methods Med. 2022 Oct 4;2022:7153491. doi: 10.1155/2022/7153491. eCollection 2022.
5
Identification of Potential Diagnostic Biomarkers and Biological Pathways in Hypertrophic Cardiomyopathy Based on Bioinformatics Analysis.基于生物信息学分析的肥厚型心肌病潜在诊断生物标志物和生物学途径的鉴定。
Genes (Basel). 2022 Mar 17;13(3):530. doi: 10.3390/genes13030530.
6
Identification of biomarkers correlated with hypertrophic cardiomyopathy with co-expression analysis.基于共表达分析鉴定与肥厚型心肌病相关的生物标志物。
J Cell Physiol. 2019 Dec;234(12):21999-22008. doi: 10.1002/jcp.28762. Epub 2019 May 6.
7
Machine learning-driven diagnostic signature provides new insights in clinical management of hypertrophic cardiomyopathy.机器学习驱动的诊断特征为肥厚型心肌病的临床管理提供了新的见解。
ESC Heart Fail. 2024 Aug;11(4):2234-2248. doi: 10.1002/ehf2.14762. Epub 2024 Apr 17.
8
Identification of Underlying Hub Genes Associated with Hypertrophic Cardiomyopathy by Integrated Bioinformatics Analysis.通过综合生物信息学分析鉴定与肥厚型心肌病相关的潜在核心基因
Pharmgenomics Pers Med. 2021 Jul 12;14:823-837. doi: 10.2147/PGPM.S314880. eCollection 2021.
9
Identification and verification of promising diagnostic biomarkers in patients with hypertrophic cardiomyopathy associate with immune cell infiltration characteristics.肥厚型心肌病患者中与免疫细胞浸润特征相关的有前景的诊断生物标志物的识别与验证。
Life Sci. 2021 Nov 15;285:119956. doi: 10.1016/j.lfs.2021.119956. Epub 2021 Sep 11.
10
Identification of key genes for hypertrophic cardiomyopathy using integrated network analysis of differential lncRNA and gene expression.通过差异lncRNA和基因表达的综合网络分析鉴定肥厚型心肌病的关键基因
Front Cardiovasc Med. 2022 Aug 4;9:946229. doi: 10.3389/fcvm.2022.946229. eCollection 2022.

引用本文的文献

1
Enhanced neoangiogenesis and balance of the immune response mediated by the Wilms' tumor suppressor WT1 favor repair after myocardial infarction.肾母细胞瘤抑癌基因WT1介导的新生血管生成增强及免疫反应平衡有利于心肌梗死后的修复。
Theranostics. 2025 Jun 9;15(14):6593-6614. doi: 10.7150/thno.104329. eCollection 2025.
2
A Machine Learning-Based Diagnostic Nomogram for Moyamoya Disease: The Validation of Hypoxia-Immune Gene Signatures.一种基于机器学习的烟雾病诊断列线图:缺氧免疫基因特征的验证
Bioengineering (Basel). 2025 May 27;12(6):577. doi: 10.3390/bioengineering12060577.
3
IKZF1 as a potential therapeutic target for dendritic cell-mediated immunotherapy in IgA nephropathy.

本文引用的文献

1
Overexpression of dimethylarginine dimethylaminohydrolase 1 protects from angiotensin II-induced cardiac hypertrophy and vascular remodeling.二甲基精氨酸二甲胺水解酶1的过表达可预防血管紧张素II诱导的心脏肥大和血管重塑。
Am J Physiol Heart Circ Physiol. 2021 Nov 1;321(5):H825-H838. doi: 10.1152/ajpheart.00064.2021. Epub 2021 Sep 17.
2
Bioinformatics and Immune Infiltration Analyses Reveal the Key Pathway and Immune Cells in the Pathogenesis of Hypertrophic Cardiomyopathy.生物信息学与免疫浸润分析揭示肥厚型心肌病发病机制中的关键途径及免疫细胞
Front Cardiovasc Med. 2021 Aug 23;8:696321. doi: 10.3389/fcvm.2021.696321. eCollection 2021.
3
IKZF1作为IgA肾病中树突状细胞介导的免疫治疗的潜在治疗靶点。
Cell Commun Signal. 2025 May 7;23(1):216. doi: 10.1186/s12964-025-02196-x.
4
Protein interactions, network pharmacology, and machine learning work together to predict genes linked to mitochondrial dysfunction in hypertrophic cardiomyopathy.蛋白质相互作用、网络药理学和机器学习共同作用,以预测与肥厚型心肌病中线粒体功能障碍相关的基因。
Sci Rep. 2025 Apr 29;15(1):15017. doi: 10.1038/s41598-025-97534-x.
5
A causal association between immune cells and hypertrophic cardiomyopathy: A bidirectional Mendelian randomization study.免疫细胞与肥厚型心肌病之间的因果关联:一项双向孟德尔随机化研究。
Genes Dis. 2025 Jan 21;12(4):101539. doi: 10.1016/j.gendis.2025.101539. eCollection 2025 Jul.
6
Comprehensive Plasma Proteomic Profiling Reveals Differentially Regulated Signaling Pathways Underlying Left Ventricular Hypertrophy Between Hypertrophic Cardiomyopathy and Aortic Stenosis.综合血浆蛋白质组学分析揭示肥厚型心肌病和主动脉瓣狭窄所致左心室肥厚背后信号通路的差异调节。
J Cardiovasc Transl Res. 2025 Apr 14. doi: 10.1007/s12265-025-10618-x.
7
Identification of and as novel key genes and drug candidates in hypertrophic cardiomyopathy: integrative bioinformatics and experimental validation.鉴定和作为肥厚型心肌病的新型关键基因及药物候选物:综合生物信息学与实验验证。
Front Mol Biosci. 2024 Sep 12;11:1458434. doi: 10.3389/fmolb.2024.1458434. eCollection 2024.
8
A personalized mRNA signature for predicting hypertrophic cardiomyopathy applying machine learning methods.应用机器学习方法的预测肥厚型心肌病的个性化 mRNA 特征。
Sci Rep. 2024 Jul 24;14(1):17023. doi: 10.1038/s41598-024-67201-8.
9
Transcriptomic Analyses and Experimental Validation Identified Immune-Related lncRNA-mRNA Pair - Regulating the Progression of Hypertrophic Cardiomyopathy.转录组分析与实验验证确定了免疫相关lncRNA-mRNA对——调控肥厚型心肌病的进展
Int J Mol Sci. 2024 Feb 29;25(5):2816. doi: 10.3390/ijms25052816.
Targeting E3 Ubiquitin Ligase WWP1 Prevents Cardiac Hypertrophy Through Destabilizing DVL2 via Inhibition of K27-Linked Ubiquitination.
靶向 E3 泛素连接酶 WWP1 通过抑制 K27 连接泛素化来破坏 DVL2,从而防止心肌肥厚。
Circulation. 2021 Aug 31;144(9):694-711. doi: 10.1161/CIRCULATIONAHA.121.054827. Epub 2021 Jun 18.
4
Identification of three novel pathogenic mutations in sarcomere genes associated with familial hypertrophic cardiomyopathy based on multi-omics study.基于多组学研究鉴定与家族性肥厚型心肌病相关的肌节基因中的三个新的致病性突变。
Clin Chim Acta. 2021 Sep;520:43-52. doi: 10.1016/j.cca.2021.05.034. Epub 2021 Jun 1.
5
Oncogenic LncRNA CASC9 in Cancer Progression.致癌长链非编码 RNA CASC9 在癌症进展中的作用。
Curr Pharm Des. 2021;27(4):575-582. doi: 10.2174/1381612826666200917150130.
6
Association between myocardial hypoxia and fibrosis in hypertrophic cardiomyopathy: analysis by T2* BOLD and T1 mapping MRI.肥厚型心肌病中心肌缺氧与纤维化的相关性:T2* 弛豫时间对比增强磁共振和 T1 mapping 分析。
Eur Radiol. 2020 Aug;30(8):4327-4336. doi: 10.1007/s00330-020-06779-9. Epub 2020 Mar 24.
7
Metabolic Changes Accompanying Spermatogonial Stem Cell Differentiation.伴随精原干细胞分化的代谢变化。
Dev Cell. 2020 Feb 24;52(4):399-411. doi: 10.1016/j.devcel.2020.01.014.
8
Practical management of chronic breathlessness.慢性呼吸困难的实际管理
BMJ. 2016 Jul 14;354:h6200. doi: 10.1136/sbmj.h6200.
9
[Hypertrophic cardiomyopathy: current state of the problem].[肥厚型心肌病:问题现状]
Khirurgiia (Mosk). 2019(1):83-88. doi: 10.17116/hirurgia201901183.
10
Cardiomyocyte dimethylarginine dimethylaminohydrolase1 attenuates left-ventricular remodeling after acute myocardial infarction: involvement in oxidative stress and apoptosis.心肌细胞二甲基精氨酸二甲氨基水解酶 1 减轻急性心肌梗死后左心室重构:涉及氧化应激和细胞凋亡。
Basic Res Cardiol. 2018 Jun 11;113(4):28. doi: 10.1007/s00395-018-0685-y.